Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
about
Efficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis.Arterial stiffness and cardiovascular therapyEffects of thiazolidinedione therapy on inflammatory markers of type 2 diabetes: a meta-analysis of randomized controlled trialsThiazolidinediones improve flow-mediated dilation: a meta-analysis of randomized clinical trials.Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions.Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels.Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.IL-1 Inhibition and Vascular Function in CKD.Renal function preservation with pioglitazone or with basal insulin as an add-on therapy for patients with type 2 diabetes mellitus.Insulin resistance in chronic kidney disease.
P2860
Q33687578-90AE76D7-7234-4457-8AE9-C5E8C6F941DCQ34079790-7F19F265-CD9D-4AAB-897D-F72656E6D409Q35510830-F5800E50-7772-42ED-83E4-AD42A2A7F965Q35874542-44FA93DB-337C-4ED7-8D09-AA453F2F5408Q38587721-CF74FCAF-F849-443A-A658-C90725357FACQ39158946-64156C6E-3045-4D0A-8555-30BBFFEC7EA3Q42068501-BEE8CB80-C3A4-4C51-B0D3-BD963A020A8DQ43660294-9ABA909D-2833-4A03-BFC2-C7CCE7E87963Q48040831-0392A0B7-F73F-4BA5-B786-55E3BF2E2022Q48089786-D648D004-5073-476C-8863-35FF76DFBD77Q49859006-C5488944-B60E-470D-A335-0FB89D29AF3E
P2860
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
@en
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
@nl
type
label
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
@en
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
@nl
prefLabel
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
@en
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
@nl
P2860
P356
P1476
Rosiglitazone does not improve vascular function in subjects with chronic kidney disease
@en
P2093
Doris T Chan
Gursharan K Dogra
P2860
P304
P356
10.1093/NDT/GFR049
P407
P577
2011-03-04T00:00:00Z